This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 834,601 Years Active: 2001
Title: Innovations by Toshio Okabe in Pharmaceutical Preparations
Introduction
Toshio Okabe is a notable inventor based in Saitama, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug formulations. His work focuses on enhancing the bioavailability of medications, which is crucial for effective treatment outcomes.
Latest Patents
One of Toshio Okabe's key patents is titled "Process for producing efonidipine hydrochloride preparations." This patent describes a method for creating an amorphous solid dispersion of efonidipine hydrochloride that exhibits high intestinal absorbability. The process involves subjecting a mixture containing efonidipine hydrochloride, hydroxypropylmethylcellulose acetate succinate, and optionally a thermostabilizer to heat treatment or mechanochemical treatment. This innovative approach allows for the production of solid dispersions without the need for organic solvents, making it advantageous for pharmaceutical manufacturing. Toshio Okabe holds 1 patent in this area.
Career Highlights
Throughout his career, Toshio Okabe has focused on improving drug formulations to enhance their effectiveness. His innovative methods have the potential to revolutionize how certain medications are produced and administered. His dedication to research and development in the pharmaceutical industry has established him as a respected figure among his peers.
Collaborations
Toshio Okabe has collaborated with notable colleagues such as Toshihisa Oda and Toyohiko Bunrin. These partnerships have contributed to the advancement of his research and the successful development of his patented processes.
Conclusion
Toshio Okabe's contributions to pharmaceutical innovations, particularly in the production of efonidipine hydrochloride preparations, highlight his expertise and commitment to improving drug formulations. His work continues to influence the field and offers promising advancements for future pharmaceutical applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile